Cargando…

Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19

To investigate the immune status of people who previously had COVID-19 infections, we recruited two-week postrecovery patients and analyzed circulating cytokine and lymphocyte subsets. We measured levels of total lymphocytes, CD3(+) T cells, CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasichaolu, Zhang, Xinri, Li, Xin, Li, Dongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695995/
https://www.ncbi.nlm.nih.gov/pubmed/33274223
http://dx.doi.org/10.1155/2020/7570981
_version_ 1783615307893440512
author Hasichaolu,
Zhang, Xinri
Li, Xin
Li, Xin
Li, Dongyan
author_facet Hasichaolu,
Zhang, Xinri
Li, Xin
Li, Xin
Li, Dongyan
author_sort Hasichaolu,
collection PubMed
description To investigate the immune status of people who previously had COVID-19 infections, we recruited two-week postrecovery patients and analyzed circulating cytokine and lymphocyte subsets. We measured levels of total lymphocytes, CD3(+) T cells, CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(+) NK cells and the serum concentrations of interleukin- (IL-) 1, IL-4, IL-6, IL-8, IL-10, transforming growth factor beta (TGF-β), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) by flow cytometry. We found that in most postrecovery patients, levels of total lymphocytes (66.67%), CD3(+) T cells (54.55%), CD4(+) T cells (54.55%), CD8(+) T cells (81.82%), CD19(+) B cells (69.70%), and CD56(+) NK cells (51.52%) remained lower than normal, whereas most patients showed normal levels of IL-2 (100%), IL-4 (80.88%), IL-6 (79.41%), IL-10 (98.53%), TNF-α (89.71%), IFN-γ (100%), and IL-17 (97.06%). Compared to healthy controls, two-week postrecovery patients had significantly lower absolute numbers of total lymphocytes, CD3(+) T cells, CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(+) NK cells, along with significantly higher levels of IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and IL-17. Among postrecovery patients, T cells, particularly CD4(+) T cells, were positively correlated with CD19(+) B cell counts. Additionally, CD8(+) T cells were positively correlated with CD4(+) T cells and IL-2 levels, and IL-6 positively correlated with TNF-α and IFN-γ. These correlations were not observed in healthy controls. By ROC curve analysis, postrecovery decreases in lymphocyte subsets and increases in cytokines were identified as independent predictors of rehabilitation efficacy. These findings indicate that the immune system gradually recovers following COVID-19 infection; however, the sustained hyperinflammatory response for more than 14 days suggests a need to continue medical observation following discharge from the hospital. Longitudinal studies of a larger cohort of recovered patients are needed to fully understand the consequences of the infection.
format Online
Article
Text
id pubmed-7695995
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76959952020-12-02 Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19 Hasichaolu, Zhang, Xinri Li, Xin Li, Xin Li, Dongyan Biomed Res Int Research Article To investigate the immune status of people who previously had COVID-19 infections, we recruited two-week postrecovery patients and analyzed circulating cytokine and lymphocyte subsets. We measured levels of total lymphocytes, CD3(+) T cells, CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(+) NK cells and the serum concentrations of interleukin- (IL-) 1, IL-4, IL-6, IL-8, IL-10, transforming growth factor beta (TGF-β), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) by flow cytometry. We found that in most postrecovery patients, levels of total lymphocytes (66.67%), CD3(+) T cells (54.55%), CD4(+) T cells (54.55%), CD8(+) T cells (81.82%), CD19(+) B cells (69.70%), and CD56(+) NK cells (51.52%) remained lower than normal, whereas most patients showed normal levels of IL-2 (100%), IL-4 (80.88%), IL-6 (79.41%), IL-10 (98.53%), TNF-α (89.71%), IFN-γ (100%), and IL-17 (97.06%). Compared to healthy controls, two-week postrecovery patients had significantly lower absolute numbers of total lymphocytes, CD3(+) T cells, CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(+) NK cells, along with significantly higher levels of IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and IL-17. Among postrecovery patients, T cells, particularly CD4(+) T cells, were positively correlated with CD19(+) B cell counts. Additionally, CD8(+) T cells were positively correlated with CD4(+) T cells and IL-2 levels, and IL-6 positively correlated with TNF-α and IFN-γ. These correlations were not observed in healthy controls. By ROC curve analysis, postrecovery decreases in lymphocyte subsets and increases in cytokines were identified as independent predictors of rehabilitation efficacy. These findings indicate that the immune system gradually recovers following COVID-19 infection; however, the sustained hyperinflammatory response for more than 14 days suggests a need to continue medical observation following discharge from the hospital. Longitudinal studies of a larger cohort of recovered patients are needed to fully understand the consequences of the infection. Hindawi 2020-11-26 /pmc/articles/PMC7695995/ /pubmed/33274223 http://dx.doi.org/10.1155/2020/7570981 Text en Copyright © 2020 Hasichaolu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hasichaolu,
Zhang, Xinri
Li, Xin
Li, Xin
Li, Dongyan
Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title_full Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title_fullStr Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title_full_unstemmed Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title_short Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
title_sort circulating cytokines and lymphocyte subsets in patients who have recovered from covid-19
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695995/
https://www.ncbi.nlm.nih.gov/pubmed/33274223
http://dx.doi.org/10.1155/2020/7570981
work_keys_str_mv AT hasichaolu circulatingcytokinesandlymphocytesubsetsinpatientswhohaverecoveredfromcovid19
AT zhangxinri circulatingcytokinesandlymphocytesubsetsinpatientswhohaverecoveredfromcovid19
AT lixin circulatingcytokinesandlymphocytesubsetsinpatientswhohaverecoveredfromcovid19
AT lixin circulatingcytokinesandlymphocytesubsetsinpatientswhohaverecoveredfromcovid19
AT lidongyan circulatingcytokinesandlymphocytesubsetsinpatientswhohaverecoveredfromcovid19